A Bayes-Genis
Overview
Explore the profile of A Bayes-Genis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
609
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gonzalez-Juanatey J, Anguita-Sanchez M, Bayes-Genis A, Comin-Colet J, Garcia-Quintana A, Recio-Mayoral A, et al.
Rev Clin Esp (Barc)
. 2022 Apr;
222(6):359-369.
PMID: 35473692
Despite currently available treatments, risk of death and hospitalizations in patients with heart failure with reduced ejection fraction (HFrEF) remains high. The pathophysiology of HFrEF includes neurohormonal activation characterized by...
2.
Teis A, Cediel G, Amigo N, Julve J, Aranyo J, Andres-Cordon J, et al.
Sci Rep
. 2021 Feb;
11(1):3141.
PMID: 33542459
Evidence regarding any association of HDL-particle (HDL-P) derangements and HDL-cholesterol content with cardiovascular (CV) death in chronic heart failure (HF) is lacking. To investigate the prognostic value of HDL-P size...
3.
Revuelta-Lopez E, Lupon J, Lax A, Pascual-Figal D, Bayes-Genis A
J Cardiovasc Transl Res
. 2020 Jan;
13(5):864-866.
PMID: 31970669
Recently, novel findings about the interleukin 1β (IL-1 β) axis in acute decompensated heart failure (ADHF) have been published. There is a positive correlation between IL-1 β and interleukin-1 receptor...
4.
Asensio-Lopez M, Lax A, Fernandez Del Palacio M, Sassi Y, Hajjar R, Januzzi J, et al.
J Mol Cell Cardiol
. 2019 Apr;
130:216-233.
PMID: 30998979
Background: The cardioprotective effects of metformin remain poorly defined. Interleukin (IL)-33/ST2L signaling is a novel cardioprotective pathway, which is antagonized by the soluble isoform sST2. No data exist about the...
5.
Garcia-Garcia C, Rueda F, Lupon J, Oliveras T, Labata C, Ferrer M, et al.
Eur Heart J Acute Cardiovasc Care
. 2018 Sep;
9(4_suppl):S161-S168.
PMID: 30175597
Background: Primary ventricular fibrillation is an ominous complication of ST-segment elevation myocardial infarction, and proper biomarkers for risk prediction are lacking. Growth differentiation factor-15 is a marker of inflammation, oxidative...
6.
Echeverria P, Gomez-Mora E, Roura S, Bonjoch A, Puig J, Perez-Alvarez N, et al.
J Antimicrob Chemother
. 2017 Apr;
72(7):2049-2054.
PMID: 28369542
Background: The effect of ART on endothelial cell function is incompletely characterized. Methods: We performed a 24 week prospective, case-control and comparative pilot study of ART-naive HIV-infected patients who started...
7.
Samouillan V, Revuelta-Lopez E, Soler-Botija C, Dandurand J, Benitez-Amaro A, Nasarre L, et al.
Biochim Biophys Acta Mol Basis Dis
. 2017 Mar;
1863(6):1500-1509.
PMID: 28245984
Adverse cardiac remodeling after myocardial infarction (MI) causes impaired ventricular function and heart failure. Histopathological characterization is commonly used to detect the location, size and shape of MI sites. However,...
8.
Pascual-Figal D, Casademont J, Lobos J, Pinera P, Bayes-Genis A, Ordonez-LLanos J, et al.
Rev Clin Esp (Barc)
. 2016 Apr;
216(6):313-22.
PMID: 27039260
Natriuretic peptides are a useful laboratory tool for the diagnosis, prognosis and treatment of patients with heart failure. Natriuretic peptides are used in various healthcare settings (consultations, emergency department, hospitalization,...
9.
de Gonzalo-Calvo D, Cenarro A, Martinez-Bujidos M, Badimon L, Bayes-Genis A, Ordonez-LLanos J, et al.
Int J Cardiol
. 2015 Aug;
201:20-9.
PMID: 26285183
Background: There is clinical interest in identifying novel lipid biomarkers for evaluating cardiovascular risk and targeting lipid-lowering treatment. Low-density lipoprotein receptor-related protein 1 (LRP1) plays a crucial role in the...
10.
Padwal R, McAlister F, McMurray J, Cowie M, Rich M, Pocock S, et al.
Int J Obes (Lond)
. 2013 Nov;
38(8):1110-4.
PMID: 24173404
Background: In heart failure (HF), obesity, defined as body mass index (BMI) ≥30 kg m(-2), is paradoxically associated with higher survival rates compared with normal-weight patients (the 'obesity paradox'). We...